Journal Mobile Options
Table of Contents
Vol. 25, No. 3, 2007
Issue release date: September 2007
Section title: Stomach
Dig Dis 2007;25:222–224
(DOI:10.1159/000103889)

Molecular Epidemiology of Gastric Cancer

Starzyńska T.
Department of Gastroenterology, Pomeranian Medical Academy, Szczecin, Poland
email Corresponding Author

Teresa Starzyńska

Department of Gastroenterology, Pomeranian Medical Academy

ul. Unii Lubelskiej 1

PL–71-252 Szczecin (Poland)

Tel./Fax +48 91 425 32 11, E-Mail testa@sci.pam.szczecin.pl


References

  1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
  2. Chen Y-C, Hunter DJ: Molecular epidemiology of cancer. CA Cancer J Clin 2005;55:45–54.
  3. Suganuma M, Kuzuhara T, Yamaguchi K, Fujiki H: Cancerogenic role of tumour necrosis factor-α inducing protein of Helicobacter pylori in human stomach. J Biochem Mol Biol 2006;39:1–8.
  4. Houghton J, Stoicov C, Roger A, Carbon J, Li H, Cai X, Fox J, Goldering J, Wang T: Gastric cancer originating from bone marrow-derived cells. Science 2004;306:1568–1571.
  5. Stadtlander CH, Waterbor JW: Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999;20:2195–2208.
  6. Corvalan A, Ding S, Koriyama C, Carrascal E, Carrasquilla G, Backhouse C, Urza L, Argadona J, Palma M, Eizuru Y, Akiba S: Association of a distinctive statin of Epstein-Barr virus with gastric cancer. Int J Cancer 2006;118:1736–1742.
  7. Ojima H, Saito K, Yamauchi H, Yamaki E, Idetu A, Hosouchi Y, Nishida Y, Tukada K, Kato H, Kuwano H: p16 protein abnormality in Epstein-Barr virus-associated gastric carcinoma. Anticancer Res 2006;26:933–937.
  8. Shin SK, Li MS, Fuerst F, Hotchkiss E, Meyer R, Kim IT, Goel A, Boland CR: Oncogenic T-antigen of JC virus is present frequently in human gastric cancer. Cancer 2006;107:481–488.
  9. El-Omar EM, Carrington M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398–402. Erratum in Nature 2001;412:99.
  10. Starzynska T, Malfertheiner P: Helicobacter and digestive malignancies. Helicobacter 2006;11:32–35.
  11. Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A, Ishizaki T: Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther 2005;22:1033–1040.
  12. Jakubowska A, Scott R, Menkiszak J, Gronwald J, Byrski T, Huzarski T, Górskii B, Cybulski C, Dębniak T, Kowalska E, Starzyńska T, Ławniczak M, Narod S, Lubiński J: A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer. Eur J Hum Genet 2003;12:955–958.

    External Resources